| Literature DB >> 30374342 |
Rosana Sousa1, Viviane M Andrade1, Thomas Bair2, Nicholas A Ettinger3, Luana Guimarães1, Laura Andrade1, Luiz H Guimarães4,5, Paulo R L Machado1,5, Edgar M Carvalho1,5,6, Mary E Wilson7, Albert Schriefer1,5,8.
Abstract
Leishmania braziliensis is an intracellular parasite that resides mostly in macrophages. Both the parasite genome and the clinical disease manifestations show considerable polymorphism. Clinical syndromes caused by L. braziliensis include localized cutaneous (CL), mucosal (ML), and disseminated leishmaniasis (DL). Our prior studies showed that genetically distinct L. braziliensis clades associate with different clinical types. Herein, we hypothesized that: (1) L. braziliensis induces changes in macrophage gene expression that facilitates infection; (2) infection of macrophages with strains associated with CL (clade B), ML (clade C), or DL (clade A) will differentially affect host cell gene expression, reflecting their different pathogenic mechanisms; and (3) differences between the strains will be reflected by differences in macrophage gene expression after initial exposure to the parasite. Human monocyte derived macrophages were infected with L. braziliensis isolates from clades A, B, or C. Patterns of gene expression were compared using Affymetrix DNA microarrays. Many transcripts were significantly decreased by infection with all isolates. The most dramatically decreased transcripts encoded proteins involved in signaling pathways, apoptosis, or mitochondrial oxidative phosphorylation. Some transcripts encoding stress response proteins were up-regulated. Differences between L. braziliensis clades were observed in the magnitude of change, rather than the identity of transcripts. Isolates from subjects with metastatic disease (ML and DL) induced a greater magnitude of change than isolates from CL. We conclude that L. braziliensis enhances its intracellular survival by inhibiting macrophage pathways leading to microbicidal activity. Parasite strains destined for dissemination may exert a more profound suppression than less invasive L. braziliensis strains that remain near the cutaneous site of inoculation.Entities:
Keywords: Leishmania braziliensis; cutaneous; disseminated; gene expression; leishmaniasis; macrophage; muco-cutaneous; strains
Year: 2018 PMID: 30374342 PMCID: PMC6196312 DOI: 10.3389/fmicb.2018.02464
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Examples of human monocyte derived macrophage genes whose expression was significantly changed by infection with L. braziliensis belonging to clades A, B, or C from Corte de Pedra (Statistical analyses by one-way ANOVA).
| Functional group | Gene | Log2 change in expression relative to uninfected MDMs | Gene description | |||||
|---|---|---|---|---|---|---|---|---|
| A | B | C | Clade | |||||
| A | B | C | ||||||
| Surface receptors | TLR8 | 9.15004e-005 | 0.0017291 | 8.18538e-005 | -2.5 | -1.9 | -2.5 | Toll-like receptor 8 |
| IL-12RB1 | 5.44261e-005 | 0.000572767 | 0.00147462 | -1.8 | -1.5 | -1.5 | Interleukin 12 receptor, beta one subunit | |
| IL-15RA | 2.01434e-005 | 0.000597875 | 0.000135149 | -2.2 | -1.7 | -1.9 | Interleukin 15 receptor, alpha subunit | |
| Signal transduction | MYD88 | 3.33232e-005 | 0.000460159 | 0.000161814 | -1.7 | -1.5 | -1.6 | Myeloid differentiation primary response (88); Activates NF-kB |
| PELI1 | 0.000140615 | 0.00015842 | 4.70314e-005 | -1.9 | -1.9 | -2.1 | Pellino-related intracellular-signaling molecule; Activates NF-kB | |
| ECT2 | 6.22083e-005 | 0.000954735 | 0.00019954 | -2.6 | -2.0 | -2.3 | Epithelial cell transfer sequence 2 oncogene; Activates NF-kB | |
| VISA | 0.000291381 | 4.07134e-005 | 0.000187217 | -1.7 | -2.0 | -1.8 | Virus-induced signaling adapter; Activates NF-kB | |
| NOD2 | 3.23249e-005 | 9.92379e-006 | 1.90858e-005 | -2.4 | -2.7 | -2.5 | Nuclear-binding oligomerization domain contining 2; Activates NF-kB | |
| STAT1 | 6.06884e-005 | 0.00179476 | 3.96141e-005 | -1.4 | -1.2 | -1.4 | Signal transduction and activation of transcription 1 JAK-STAT pathway | |
| STAT5A | 3.97644e-005 | 0.00148146 | 0.000634802 | -1.6 | -1.4 | -1.4 | Signal transduction and activation of transcription 5 JAK-STAT pathway | |
| TYK2 | 2.32594e-005 | 0.000160678 | 3.71196e-005 | -1.8 | -1.6 | -1.7 | Non-receptor member of JAK family; JAK-STAT pathway | |
| JAK2 | 2.8929e-005 | 6.75267e-005 | 1.48982e-005 | -2.2 | -2.1 | -2.4 | Janus kinase 2; JAK-STAT pathway | |
| MAP2K5 | 0.00868219 | 0.000126235 | 9.53199e-006 | -1.2 | -1.5 | -1.7 | Mitogen-activated protein kinase kinase 5; MAPK pathway | |
| MAP2K3 | 6.23796e-005 | 0.000128993 | 6.32058e-005 | -1.9 | -1.8 | -1.9 | Mitogen-activated protein kinase kinase 3; MAPK pathway | |
| ICK | 7.68298e-005 | 0.000600357 | 3.15881e-005 | -2.3 | -1.9 | -2.5 | Intestinal cell (MAK-like) kinase; Possibly MAPK pathway | |
| TRAF7 | 2.50164e-005 | 0.000317723 | 0.0002048 | -1.4 | -1.3 | -1.3 | TNF receptor-associated factor 7; MKKK of MAPK pathway | |
| PLCB2 | 1.7885e-005 | 5.43495e-005 | 3.08817e-006 | -1.7 | -1.6 | -1.9 | Phospholipase C, beta 2 chain; Activates Phospholipase C | |
| CAMKK2 | 8.90843e-006 | 0.000102443 | 1.61629e-005 | -1.9 | -1.6 | -1.8 | Calcium/calmodulin-dependent protein kinase kinase 2 | |
| MFNG | 4.41145e-005 | 0.00259564 | 0.00011307 | -1.9 | -1.5 | -1.8 | Manic fringe; Notch signaling pathway | |
| TRERF1 | 4.08183e-005 | 0.00106701 | 0.000153032 | -1.9 | -1.6 | -1.5 | Transcriptional regulator | |
| XPO6 | 7.73493e-005 | 0.000158596 | 3.54427e-005 | -1.5 | -1.5 | -1.6 | Exportin 6; nuclear pore protein transporter | |
| RANBP10 | 2.96201e-005 | 0.000235132 | 0.000147206 | -2.0 | -1.7 | -1.8 | RAN binding prot 10; nuclear pore transport | |
| NUP62 | 4.25576e-005 | 0.000737207 | 0.000128261 | -1.4 | -1.3 | -1.4 | Nucleoporin 62 kDa | |
| NUP93 | 6.71235e-005 | 0.00070184 | 0.000213948 | -1.6 | -1.4 | -1.5 | Nucleoporin 93 kDa | |
| NUP214 | 1.07315e-005 | 0.00204607 | 0.00011174 | -1.8 | -1.3 | -1.6 | Nucleoporin 214 kDa | |
| Electron transport | ISCU | 5.90789e-006 | 4.1835e-005 | 1.09868e-005 | -1.5 | -1.4 | -1.5 | Iron–sulfur cluster scaffold homolog |
| ISCA2 | 1.49189e-005 | 0.000379011 | 2.9555e-005 | -2.4 | -1.8 | -2.3 | Iron–sulfur cluster assembly 2 homolog | |
| NDUFA11 | 1.61998e-005 | 0.000285867 | 7.42091e-006 | -1.4 | -1.3 | -1.4 | NADH dehydrogenase subunit, mitochondrial encoded | |
| NDUFC1 | 3.5465e-005 | 0.000959163 | 4.37207e-005 | -1.4 | -1.3 | -1.4 | NADH dehydrogenase subunit, mitochondrial encoded | |
| NDUFB10 | 9.64108e-006 | 0.000432758 | 5.43291e-005 | -1.5 | -1.3 | -1.4 | NADH dehydrogenase subunit, mitochondrial encoded | |
| NDUFV3 | 4.55964e-006 | 0.000170585 | 1.11309e-005 | -1.8 | -1.5 | -1.7 | NADH dehydrogenase subunit, mitochondrial encoded | |
| NDUFS3 | 3.86571e-007 | 1.31216e-005 | 8.56046e-007 | -1.6 | -1.4 | -1.5 | NADH dehydrogenase subunit, mitochondrial encoded | |
| NDUFS2 | 3.55512e-005 | 0.000983593 | 0.000288838 | -1.7 | -1.4 | -1.5 | NADH dehydrogenase subunit, mitochondrial encoded | |
| NDUFB8 | 8.34828e-005 | 0.000590415 | 0.0012524 | -1.3 | -1.2 | -1.2 | NADH dehydrogenase subunit, mitochondrial encoded | |
| TFAM | 3.42623e-005 | 0.00349217 | 8.02956e-005 | -1.5 | -1.3 | -1.5 | Transcription factor A, mitochondrial; encoded in the nucleus | |
| Mitochondrial protein | MRPS14 | 8.24489e-005 | 0.000132693 | 0.000467884 | -2.3 | -2.2 | -2.0 | Mitochondrial ribosomal protein S14; encoded in the nucleus |
| synthesis | MRPS35 | 1.0742e-005 | 0.00014928 | 1.28405e-005 | -1.5 | -1.4 | -1.5 | Mitochondrial ribosomal protein S35; encoded in the nucleus |
| MRPL16 | 2.17496e-005 | 0.000230342 | 8.89629e-005 | -2.0 | -1.7 | -1.8 | Mitochondrial ribosomal protein L16; encoded in the nucleus | |
| MRPL19 | 0.000265737 | 0.00231705 | 7.0312e-005 | -1.8 | -1.5 | -1.9 | Mitochondrial ribosomal protein L19; encoded in the nucleus | |
| MRPL41 | 4.5838e-005 | 0.00148749 | 0.000301997 | -1.7 | -1.4 | -1.5 | Mitochondrial ribosomal protein L41; encoded in the nucleus | |
| MRPL52 | 7.55371e-005 | 0.00318154 | 0.00012328 | -1.5 | -1.3 | -1.5 | Mitochondrial ribosomal protein L52; encoded in the nucleus | |
| MRP63 | 8.37002e-005 | 0.00353342 | 0.000356301 | -1.6 | -1.4 | -1.5 | Mitochondrial ribosomal protein 63; encoded in the nucleus | |
| PDHB | 8.56049e-005 | 0.00209902 | 0.000120183 | -1.8 | -1.5 | -1.7 | Pyruvate dehydrogenase (lipoamide) beta | |
| TP53 | 0.000833372 | 0.0018592 | 7.78129e-005 | -1.5 | -1.5 | -1.8 | Tumor protein p53; Tumor suppressor | |
| MAPK14 | 2.07957e-005 | 0.000172754 | 5.78548e-005 | -1.7 | -1.5 | -1.6 | Phosphorylates and activates TP53 | |
| FRAP1 | 7.21564e-005 | 0.000895603 | 0.000148447 | -2.2 | -1.8 | -2.0 | Phosphorylates and activates TP53 | |
| YPEL3 | 1.10105e-005 | 0.000141583 | 2.17379e-005 | -2.9 | -2.2 | -2.7 | Tumor suppressor directly induced by TP53 | |
| MRPL41 | 4.5838e-005 | 0.00148749 | 0.000301997 | -1.7 | -1.4 | -1.5 | TP53 translocation to mitochondrion | |
| LRRK2 | 0.000111713 | 0.00051427 | 7.7878e-005 | -3.9 | -3.1 | -4.1 | PARK8; Induces apoptosis; Interacts with PARKIN and DJ-1 | |
| DJ-1 | 8.46957e-006 | 0.0013984 | 0.000116928 | -1.3 | -1.2 | -1.2 | PARK7; Redox-sensitive chaperone and sensor of oxidative stress | |
| NUB1 | 0.000155931 | 0.000373989 | 6.53521e-005 | -1.7 | -1.6 | -1.7 | Negative regulator of ubiquitin-like proteins 1; Part of Lewy bodies | |
| HIC1 | 5.26337e-005 | 0.000501033 | 0.00023281 | 3.6 | 2.7 | 2.9 | Transcription repressor Hypermethylated in Cancer 1 | |
| ETS2 | 4.80848e-005 | 0.000607089 | 0.000184372 | 2.4 | 1.9 | 2.1 | Probably transcriptional activator of TP53 | |
| UBC | 7.4032e-005 | 0.00237149 | 0.000111829 | 1.2 | 1.1 | 1.2 | Ubiquitin C; proteasome | |
| UBAP1 | 3.48504e-005 | 0.000293469 | 0.000225023 | 1.5 | 1.4 | 1.4 | Ubiquitin associated protein 1 target ubiquitinilation | |
| SPSB1 | 7.87991e-005 | 0.000339641 | 0.000157297 | 2.4 | 2.1 | 2.2 | Substrate recognition-E3 ubiquitin–protein ligase complex | |
| KLHL21 | 5.79205e-005 | 0.000134488 | 3.97511e-005 | 1.7 | 1.6 | 1.7 | Kelch-like 21; Adapter of an E3 ubiquitin-protein ligase complex | |
| USP12 | 9.3778e-005 | 0.000972177 | 0.000104449 | 1.6 | 1.4 | 1.5 | Ubiquitin specific peptidase 12; Deubiquitinating enzyme | |
| Metal binding | MT1M | 9.05665e-005 | 0.000215829 | 2.07091e-005 | 7.6 | 6.3 | 11.0 | Metallothionein 1M |
| MT1X | 0.000232234 | 0.000598304 | 5.30768e-005 | 2.7 | 2.4 | 3.2 | Metallothionein 1X | |
| MT1F | 0.000211204 | 0.000573519 | 4.83875e-005 | 2.6 | 2.4 | 3.2 | Metallothionein 1F | |
| MT1E | 8.88948e-006 | 2.39768e-005 | 2.1035e-006 | 3.4 | 3.0 | 4.2 | Metallothionein 1E | |
| MT1G | 1.43444e-006 | 6.48199e-006 | 4.16245e-007 | 2.7 | 2.4 | 3.1 | Metallothionein 1G | |
| MT1H | 1.17455e-005 | 4.00175e-005 | 3.2461e-006 | 2.7 | 2.4 | 3.1 | Metallothionein 1H | |
| Antioxidant response | TXNRD1 | 5.75177e-006 | 6.15629e-006 | 2.27237e-006 | 1.3 | 1.3 | 1.4 | Thioredoxin reductase 1 |
| Stress response | HSPA1A | 7.71182e-005 | 0.000256787 | 5.82824e-005 | 5.8 | 4.6 | 6.1 | Heat shock 70 kDa protein 1A |
Changes in expression of 10 transcripts in MDMs infected with L. braziliensis isolates belonging to each clades (A, B, or C) were documented in independent assays of gene expression in four MDM donors.
| Transcript | Clade | Fold change | |
|---|---|---|---|
| Microarray ( | qPCR ( | ||
| MT1M | A | 7.653 | 2.660 |
| MT1M | B | 6.269 | 2.405 |
| MT1M | C | 11.048 | 4.945 |
| HSPA1A | A | 5.763 | 4.869 |
| HSPA1A | B | 4.563 | 3.249 |
| HSPA1A | C | 6.101 | 4.414 |
| MT1X | A | 2.662 | 3.880 |
| MT1X | B | 2.384 | 2.898 |
| MT1X | C | 3.203 | 5.642 |
| TXNRD1 | A | 1.337 | 1.524 |
| TXNRD1 | B | 1.334 | 1.560 |
| TXNRD1 | C | 1.377 | 1.855 |
| UBC | A | 1.179 | 1.444 |
| UBC | B | 1.111 | 1.283 |
| UBC | C | 1.170 | 1.351 |
| DJ-1 | A | 0.406 | 0.843 |
| DJ-1 | B | 0.435 | 0.949 |
| DJ-1 | C | 0.435 | 0.985 |
| TRERF1 | A | 0.268 | 0.453 |
| TRERF1 | B | 0.330 | 0.486 |
| TRERF1 | C | 0.354 | 0.574 |
| IL-15RA | A | 0.435 | 0.624 |
| IL-15RA | B | 0.536 | 0.541 |
| IL-15RA | C | 0.467 | 0.694 |
| TLR8 | A | 0.178 | 0.435 |
| TLR8 | B | 0.268 | 0.458 |
| TLR8 | C | 0.178 | 0.482 |
| LRRK2 | A | 0.067 | 0.537 |
| LRRK2 | B | 0.117 | 0.553 |
| LRRK2 | C | 0.058 | 0.482 |
Expression kinetics of 21 transcripts significantly induced or repressed in human monocyte derived macrophages of eight donors after 4 h infection with an L. braziliensis isolate of a cutaneous leishmaniasis patient from Corte de Pedra, Brazil.
| Transcript | 4 h Mean (SE) | 24 h Mean (SE) | 48 h Mean (SE) | 4 h × 24 h × 48 h | 4 h × 24 h | 4 h × 48 h |
|---|---|---|---|---|---|---|
| LRRK2 | 0.44 (0.11) | 0.64 (0.19) | 0.30 (0.09) | 0.2637 | 0.3751 | 0.3565 |
| NUP214 | 0.55 (0.07) | 1.17 (0.10) | 0.86 (0.21) | 0.0162* | 0.0008*** | 0.1407 |
| TRERF1 | 0.55 (0.11) | 1.58 (0.40) | 1.01 (0.27) | 0.1443 | 0.0484* | 0.1874 |
| TP53 | 0.60 (0.10) | 0.88 (0.15) | 0.73 (0.19) | 0.3708 | 0.1747 | 0.6276 |
| IL10RB | 0.60 (0.13) | 1.18 (0.09) | 0.53 (0.17) | 0.0395* | 0.0087** | 0.8201 |
| MAPK14 | 0.62 (0.12) | 0.89 (0.21) | 0.71 (0.17) | 0.3497 | 0.2053 | 0.6732 |
| TLR8 | 0.68 (0.15) | 1.23 (0.29) | 0.53 (0.18) | 0.1667 | 0.2021 | 0.4237 |
| NDUFA11 | 0.70 (0.08) | 2.11 (0.57) | 0.57 (0.19) | 0.0490* | 0.0430* | 0.5232 |
| PARK7 | 0.73 (0.05) | 1.23 (0.07) | 0.76 (0.19) | 0.0304* | 0.0001*** | 0.8683 |
| XPO6 | 0.77 (0.10) | 1.56 (0.47) | 0.94 (0.30) | 0.2905 | 0.1462 | 0.6111 |
| MYD88H | 0.85 (0.11) | 1.64 (0.26) | 0.68 (0.17) | 0.0104* | 0.0384* | 0.4681 |
| FRP1 | 0.86 (0.27) | 1.61 (0.26) | 0.94 (0.23) | 0.1498 | 0.1212 | 0.8445 |
| NUP93 | 1.02 (0.24) | 1.06 (0.05) | 0.98 (0.23) | 0.9414 | 0.8573 | 0.9014 |
| IL15RA | 1.32 (0.40) | 1.37 (0.28) | 0.92 (0.22) | 0.5385 | 0.9363 | 0.4214 |
| NUB1 | 1.35 (0.37) | 2.40 (0.56) | 0.86 (0.27) | 0.0929 | 0.2262 | 0.3887 |
| UBC | 1.39 (0.30) | 3.27 (0.82) | 0.77 (0.21) | 0.0244* | 0.0154* | 0.1336 |
| TXRND1 | 1.85 (0.28) | 2.44 (0.68) | 0.87 (0.25) | 0.0621 | 0.3381 | 0.0730 |
| MT1X | 2.66 (0.69) | 1.50 (0.30) | 1.24 (0.41) | 0.1087 | 0.1084 | 0.1095 |
| MT1M | 3.20 (0.71) | 3.25 (1.04) | 0.78 (0.29) | 0.0214* | 0.9564 | 0.0058** |
| HSPA1A | 4.45 (2.14) | 2.84 (0.90) | 2.43 (1.44) | 0.6523 | 0.5278 | 0.5245 |